Magenta Therapeutics
Magenta Therapeutics is a biotechnology company using stem cells to develop cellular therapies for immune and blood-based diseases.
3
Funding Rounds
$150.5m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja*** Ga***** | - | - | linkedin twitter |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja*** Ga***** | - | - | linkedin twitter |
| Br*** Bo*** | - | - | linkedin twitter facebook |
| Je** Al**** | - | - | - |
| To* Da**** | - | - | - |
| Al**** La**** | - | - | |
| Am* Ro******* | - | - | - |
| Mi***** Va********** | - | - | - |
| An** Mc****** | - | - | - |
| Da*** Sc***** | - | - |
Funding series
Funding Series Analysis
The company Magenta Therapeutics has raised a total of $48.5m in funding over 3 rounds.
Key Insights:
- Magenta Therapeutics Series A round, November 2016: $48.5m
- Magenta Therapeutics funding round, May 2017: $50m
- Magenta Therapeutics funding round, April 2018: $52m
Magenta Therapeutics Series A round, November 2016
$48.5m
Magenta Therapeutics funding round, May 2017
$50m
Magenta Therapeutics funding round, April 2018
$52m
Industries
Magenta Therapeutics is active in the following industries:
- Biomedical engineering
- Immunotherapy
- Cell therapy
- Regenerative medicine
- Stem-cell therapy
- Stem cell technology
- Engineering
- Drug discovery
- Biotechnology
- Healthcare
- Technology
- Biology